Biography of James Healy
Last update: March 13, 2024Career
James was Board Member at ObsEva, and Board Member at Amarin Corporation. James Healy joined Sofinnova Partners in 2023.
James Healy is currently- Managing Partner at Sofinnova Investments - View - Sofinnova Investments org chart
- Director at Arrivent Biopharma - View - Arrivent Biopharma org chart
- Director at Natera - View - Natera org chart
- Director at Rapport Therapeutics - View - Rapport Therapeutics org chart
- Director at Y-mAbs Therapeutics - View - Y-mAbs Therapeutics org chart
Create your alert
to follow the career of James Healy.
Education
James Healy has a Master of Medicine from Stanford University School of Medicine in 1998 and a PhD in Immunology from Stanford University in 1998.
They have also studied at Stanford University :
Find more alumni from Stanford University
More about James Healy
Selected links
Do you need to know more about James Healy? More results.
Participate
Social media
- James Healy on Google News, Twitter, LinkedIn, YouTube
- View the pictures of James Healy
The colleagues of James Healy
Company Colleagues
- At Sofinnova Investments, James Healy has 18 colleagues including Eric Delbridge (Portfolio & Public Equity), Nathalie Auber (CFO)…
- At Arrivent Biopharma, James Healy has 20 colleagues including Bing Yao (CEO & Director), Kristine Peterson (Director)…
- At Natera, James Healy has 33 colleagues including Steve Chapman (CEO & Director), Gail Marcus (Director)…
- At Rapport Therapeutics, James Healy has 19 colleagues including Abraham Ceesay (CEO), Jeff Tong (Director)…
- At Y-mAbs Therapeutics, James Healy has 16 colleagues including Michael Rossi (CEO & Director), Laura Hamill (Director)…
Industry Colleagues
- In the Fund industry, James Healy has 21,761 colleagues in 1,475 companies located in 63 countries. 9,255 executive movements have been recorded in the last 12 months. Learn more about Fund.
Report an error
Update the org chart details of James Healy.
